Glucagon-like peptide-1 receptor agonist

Glucagon-like peptide-1 receptor agonists (GLP-1-RA) nyɛla tim tibu pubu balibu (medications) ka bɛ mali li tibiri "type 2 diabetes" mini puli piribu "obesity". ADA kali li mi m-pahi tuuli tima din tu ni di ti type 2 diabetes nima ban ni tooi gbaai doro kamani "atherosclerotic cardiovascular disease" zaŋ kana yuuni 2022. Di shɛŋa chibiri ningbungbaŋ ka shɛli vandi noli ni.

Di barinanima shɛŋa n-nyɛ "nausea", tiri ka nyera, ni puuni biɛrim. Di dii bi filindi ningbuna ni sichiri; amaa dini tooi "pancreatitis" bee "gastroparesis" na. Binkɔbiri ni tooi mali thyroid C-cell tumors. Paɣ'puhinima bi tu ni bi zaŋli voli.Di tirila GLP-1 receptor yaa. Di pahirila "insulin" yihibu ka boori glucagon zaŋ chaŋ shikiri pam polo; ka bi waɣisiri puli yom.

Tuuli GLP-1-RA, exenatide, zaŋ tum tima tuma saɣiti daa niŋla United States yuuni 2005. Zaŋ kana yuuni 2022 di daa niŋ liɣiri pam United States, ka dari Kamani 1,000 USD goli kam ni. Di zaɣ'pala yina ni "long acting insulin". Di daa dami pooi Silimiin yuuni 2023 ka di nyɛla ban borili n daa nabigi.

 Kundivihira 

Category:Translated from MDWiki